Covalent Small Molecules
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
241
NCT05683418
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 15, 2023
Completion: Dec 31, 2026
Loading map...